VWA
GILD icon

Visionary Wealth Advisors’s Gilead Sciences GILD Stock Holding History

Visionary Wealth Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-3,495
Closed -$221K – 294
2020
Q3 		$221K Buy
3,495
+50
+1% +$3.47K 0.03% 229
2020
Q2 		$265K Buy
3,445
+3
+0.1% +$230 0.04% 185
2020
Q1 		$257K Buy
3,442
+131
+4% +$9.05K 0.05% 162
2019
Q4 		$216K Buy
+3,311
New +$216K 0.04% 197

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Visionary Wealth Advisors's GILD Position: Q4 2020 in Review

Visionary Wealth Advisors sold out of Gilead Sciences (GILD) in Q4 2020, closing a stake of 3,495 shares — an estimated $221K sold.

Visionary Wealth Advisors first reported a position in GILD in Q4 2019 and held it in 4 quarters. The position peaked at $265K in Q2 2020. 1,563 funds tracked by Wall St. Rank hold GILD as of Q4 2020.

  • Visionary Wealth Advisors reported no remaining Gilead Sciences position as of Q4 2020 after selling out during the quarter.
  • Visionary Wealth Advisors sold 3,495 Gilead Sciences shares in Q4 2020, an estimated $221K.
  • Visionary Wealth Advisors first reported a position in Gilead Sciences in Q4 2019 and held it in 4 quarters.
  • Visionary Wealth Advisors's Gilead Sciences position peaked at $265K in Q2 2020.
  • 1,563 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2020.

Based on Visionary Wealth Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.